Official account of the PreDiCT-TB consortium. Updates on tuberculosis research efforts are posted including news, publications and general consortium efforts
More importantly we feel we have challenged the bottlenecks that continue to hamper our ability to create and register new medicines for TB patients, bringing new tools & understanding for scientists to use.” (2/2)
Gerry Davies comments “This has been an amazing, & we believe unique, collaboration between industry, SMEs and academics in the field of TB drug Discovery and Development that all of us have really enjoyed participating in." (1/2)
Gerry Davies and Justin Green will be supported by PreDiCT-TB project manager Philip Whitehead as they head to Brussels this Thursday to present a wide-ranging summary of the 5-year PreDiCT-TB IMI project.
Extremely happy to see our early edition AAC manuscript online today. We performed RNA sequencing on Mmar and Mtb treated with first-line antibiotics to unravel mounted stress responses. We then made indicator strains to predict MoA of anti-TB compounds: https://t.co/drocTtBZpg
See the new @PreDiCT_TB paper that proposed a simple and logical approach to inform improvements in #tuberculosis drug development and clinical trials. Read it at https://t.co/85Bv1RIn0z. @Infection_StAnd@PanACEA_II